HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Study of hyaluronan synthase inhibitor, 4-methylumbelliferone derivatives on human pancreatic cancer cell (KP1-NL).

Abstract
The structure of 4-methylumbelliferone (MU) consists of coumarin with 4-methyl group and 7-hydroxy group. MU inhibits HA synthesis and pericellular HA matrix formation. In this study, we used 10 MU derivatives which have hydroxy groups and methyl groups at various positions of coumarin to investigate a more effective HA inhibitor than MU. First, human pancreatic cancer cell (KP1-NL) growth assay was analyzed by Alamar Blue to determine the non-toxic concentration of MU derivatives, and the inhibitory effect on HA synthesis in the cell cultures was analyzed by HA measuring kit. Next, cell surfaces of cancer cells were analyzed by particle-exclusion assay. In conclusion, both hydroxy and methyl groups are necessary for HA inhibition by MU, and two hydroxy groups inhibited HA synthesis more strongly than MU.
AuthorsHajime Morohashi, Atsushi Kon, Makoto Nakai, Masanori Yamaguchi, Ikuko Kakizaki, Shuichi Yoshihara, Mutsuo Sasaki, Keiichi Takagaki
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 345 Issue 4 Pg. 1454-9 (Jul 14 2006) ISSN: 0006-291X [Print] United States
PMID16730656 (Publication Type: Journal Article)
Chemical References
  • Enzyme Inhibitors
  • Hymecromone
  • Hyaluronic Acid
  • Glucuronosyltransferase
  • Hyaluronan Synthases
Topics
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors (chemistry, pharmacology)
  • Glucuronosyltransferase (antagonists & inhibitors, metabolism)
  • Humans
  • Hyaluronan Synthases
  • Hyaluronic Acid (biosynthesis)
  • Hymecromone (analogs & derivatives, chemistry, pharmacology)
  • Pancreatic Neoplasms (enzymology, pathology)
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: